Heroin and cocaine craving and use during treatment: Measurement validation and potential relationships

Heinz, Adrienne J.; Epstein, David H.; Schroeder, Jennifer R.; Singleton, Edward G.; Heishman, Stephen J.; Preston, Kenzie L.

doi:10.1016/j.jsat.2006.05.009

Cited by 80 publications

(57 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All other scores less than a 100% were the total score divided by the 8 potential points. In addition, the other outcomes were treatment retention, treatment compliance with weekly buprenorphine urine testing and change from baseline to week 8 on repeated measures of opioid withdrawal symptoms measured by the Clinical Opiate Withdrawal Scale (COWS) 24 , opioid craving measured by Heroin Craving Questionnaire-Short Form-14 (HCQ-SF-14) 27, 28 ; and depression symptoms measured by the Center for Epidemiologic Studies Depression Scale (CES-D) 29 .…”

Section: Methodsmentioning

confidence: 99%

Buprenorphine‐naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders

et al. 2017

View full text Add to dashboard Cite

Background and Objectives Opioid use disorder among young adults is rising sharply with an increase in morbidity and mortality. This study examined differences in treatment response to a fixed dose of buprenorphine-naloxone between heroin (HU) and prescriptions opioids (POU) users. Methods 80 opioid dependent young adults (M = 22 years) were treated with buprenorphine-naloxone 16-4mg/day for 8 weeks. Differences between HU (N = 17) and POU (N = 63) on changes in weekly opioid use, opioid craving, withdrawal and depression symptoms were analyzed with mixed-effects regression models. Results The HU had an overall mean proportion of weekly opioid use of 0.32 (SD = 0.14) compared to POU’s weekly mean of 0.24 (SD = 0.15) showing a significant main effect (Z = 2.21, p = 0.02). Depressive symptoms (CES-D scores) were elevated at baseline for both groups (HU: M = 23.1, SD = 11.9; PO: M = 22.2, SD = 9.4), but only POU improved significantly to a score of 9.88 (SD = 7.4) compared to HU’s score of 18.58 (SD = 10.3) at week 8 (Z = 2.24, p = 0.02). There were no significant differences in treatment retention, craving or withdrawal symptoms. Discussion and Conclusions Treatment response to 16-4mg/day of buprenorphine-naloxone was significantly diminished for heroin users relative to opioid prescription users in weekly opioid use. Heroin users also had persistent depressive symptoms suggesting the need for close monitoring. Scientific Significance These data suggest that young heroin users might require higher doses of buprenorphine.

show abstract

Section: Methodsmentioning

confidence: 99%

Buprenorphine‐naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Further, the OCDUS and DDQ both are short-to-administer measures of cocaine craving. Other multidimensional questionnaires of craving, such as the Cocaine Craving Questionnaire (CCQ; (13)) or the 33-item Questionnaire of Cocaine Use (QCU; (22)), are more time-consuming and thus less useful for those clinicians and researchers who want to measure craving repeatedly, whereas brief measures, such as the shortened version of the CCQ or visual analogue scales, often measure a single construct and thus have lost their multidimensionality (26). Hence, the OCDUS and DDQ are both multidimensional, short-to-administer measures of cocaine craving that may be valuable adjuncts to currently available measures.…”

Section: Introductionmentioning

confidence: 99%

Validation of the cocaine versions of the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire

Lievaart

Erciyes

Veen

et al. 2015

The American Journal of Drug and Alcohol Abuse

View full text Add to dashboard Cite

Our results indicate that the OCDUS and DDQ for cocaine are both easy to administer and reliable instruments to assist the clinical practitioner or researcher to measure craving in cocaine dependent subjects. Moreover, the factor structure for the cocaine versions were similar to the heroin versions, indicating the OCDUS and the DDQ can be reliably used to measure craving for both substances, enabling a direct comparison between heroin and cocaine craving.

show abstract

“…Such assessments of self-reported drug craving have utility for predicting lapse and/or relapse (Heinz et al, 2006;Paliwal, Hyman, and Sinha, 2008) and are therefore important for researchers and clinicians who wish to assess patient outcomes. Craving assessments have been extended to many substances, including alcohol (Bohn, Krahn, and Staehler, 1995;Flannery, Volpicelli, and Pettinati 1999;Singleton, Tiffany, and Henningfield, 1994), marijuana (Heishman, Singleton, and Liguori, 2001), opiates (Franken, Hendriks, and Van-den-Brink, 2002), nicotine (Cepeda-Benito and Ruig-Ferrer, 2004;Cox, Tiffany, and Christen, 2001;Tiffany and Drobes, 1990;Toll, McKee, Krishnan-Sarin, and O'Malley, 2004), food (Cepeda-Benito et al, 2000), and importantly, cocaine (Halikas et al, 1991;Tiffany, Singleton, Haertzen, and Henningfield, 1993).…”

Section: Introductionmentioning

confidence: 99%

Two Scales to Evaluate Cocaine Craving

Muñoz

Martínez

Fernández‐Santaella

et al. 2010

Substance Use & Misuse

View full text Add to dashboard Cite

The cocaine craving questionnaire-brief (CCQ-Brief English) asks cocaine users to report their level of craving now. We constructed two brief scales of cocaine craving in a sample of 107 Spanish-speaking natives in treatment for cocaine abuse or dependence: the CCQ-Brief(Spanish) and the pictographic assessment of desire (PAD), which relies less on language. Principal component analyses yielded a one-component solution for the CCQ-Brief, explaining between 62% and 68% of the sample variability. Cronbach's alpha ranged from .92 to .94. The CCQ-Brief and the PAD were strongly correlated; effect sizes ranged from .42 to .68 in separate trials. Laboratory cue-exposure results showed that in both scales craving was higher upon presentation of cocaine-related rather than neutral pictorial stimuli. The CCQ-Brief and PAD are potentially valuable scales for evaluating cocaine craving.

show abstract

Heroin and cocaine craving and use during treatment: Measurement validation and potential relationships

Cited by 80 publications

References 30 publications

Buprenorphine‐naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders

Buprenorphine‐naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders

Validation of the cocaine versions of the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire

Two Scales to Evaluate Cocaine Craving

Contact Info

Product

Resources

About